{"pmid":32457036,"title":"ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.","text":["ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.","COVID-19 pandemic challenges health system capacities in many countries. National healthcare services have to manage unexpected shortage of healthcare resources that have to be reallocated according to the principles of fair and ethical prioritisation, in order to maintain the highest levels of care to all patients, ensure the safety of patients and healthcare workers and save as many lives as possible. Beyond that, cancer care services have to pursue restructuring, following the same evidence-based dispositions. In this article, we propose guidance to the management of colorectal cancer during the pandemic, prioritised according to a three-tiered framework, based on expert clinical judgement and magnitude of benefit expected from specific interventions. Since the availability of resources for diagnostic procedures, surgery and postoperative care, systemic therapy and radiotherapy may differ, authors did separate prioritisation analyses. The impact of postponing or abrogating cancer interventions on outcomes according to a high, medium or low priority scale, is outlined and discussed. The implementation of healthcare services using telemedicine is explored: it reveals itself as functional and effective for limiting patients' need to travel to centres and thereby has the potential to reduce diffusion of severe acute respiratory syndrome coronavirus 2. Colorectal cancer demands a considerable amount of medical resources. Therefore, the redefinition of its diagnostic and therapeutic algorithms with a rigorous method is crucial in order to ensure the highest quality of continuum of care in the broader context of the pandemic and the challenged healthcare systems.","ESMO Open","Vecchione, Loredana","Stintzing, Sebastian","Pentheroudakis, George","Douillard, Jean-Yves","Lordick, Florian","32457036"],"abstract":["COVID-19 pandemic challenges health system capacities in many countries. National healthcare services have to manage unexpected shortage of healthcare resources that have to be reallocated according to the principles of fair and ethical prioritisation, in order to maintain the highest levels of care to all patients, ensure the safety of patients and healthcare workers and save as many lives as possible. Beyond that, cancer care services have to pursue restructuring, following the same evidence-based dispositions. In this article, we propose guidance to the management of colorectal cancer during the pandemic, prioritised according to a three-tiered framework, based on expert clinical judgement and magnitude of benefit expected from specific interventions. Since the availability of resources for diagnostic procedures, surgery and postoperative care, systemic therapy and radiotherapy may differ, authors did separate prioritisation analyses. The impact of postponing or abrogating cancer interventions on outcomes according to a high, medium or low priority scale, is outlined and discussed. The implementation of healthcare services using telemedicine is explored: it reveals itself as functional and effective for limiting patients' need to travel to centres and thereby has the potential to reduce diffusion of severe acute respiratory syndrome coronavirus 2. Colorectal cancer demands a considerable amount of medical resources. Therefore, the redefinition of its diagnostic and therapeutic algorithms with a rigorous method is crucial in order to ensure the highest quality of continuum of care in the broader context of the pandemic and the challenged healthcare systems."],"journal":"ESMO Open","authors":["Vecchione, Loredana","Stintzing, Sebastian","Pentheroudakis, George","Douillard, Jean-Yves","Lordick, Florian"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32457036","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/esmoopen-2020-000826","keywords":["crc and covid-19","colorectal cancer patients during covid19 pandemic","colorectal cancer patients recommendetions"],"topics":["Prevention"],"weight":1,"_version_":1667967698990006273,"score":9.490897,"similar":[{"pmid":32423899,"title":"ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer.","text":["ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer.","The COVID-19 pandemic is challenging the capacities of health systems in many countries. National healthcare services have to manage unexpected shortages of healthcare resources that have to be re-allocated according to the principles of fair and ethical prioritisation, in order to maintain the highest levels of care to all patients, ensure the safety of patients and healthcare workers, and save as many lives as possible. Also, cancer care services have to pursue restructuring, following the same evidence-based dispositions. In this article, we propose a guidance to the management of pancreatic cancer during the pandemic, prioritised according to a three-tiered framework, and based on expert clinical judgement and magnitude of benefit expected from specific interventions. Since the availability of resources for diagnostic procedures, surgery and postoperative care, systemic therapy and radiotherapy may differ, the authors have separated the prioritisation analyses. The impact of postponing or abrogating cancer interventions on outcomes according to a high, medium or low priority scale is outlined and discussed. The implementation of healthcare services using telemedicine is explored; it reveals itself as functional and effective for limiting patients' need to travel to centres and thereby has the potential to reduce diffusion of SARS-CoV-2. Pancreatic cancer demands a considerable amount of medical resources. Therefore, the redefinition of its diagnostic and therapeutic algorithms with a rigorous method is crucial in order to ensure the highest quality of continuum of care in the broader context of the pandemic and the challenged healthcare systems.","ESMO Open","Catanese, Silvia","Pentheroudakis, George","Douillard, Jean-Yves","Lordick, Florian","32423899"],"abstract":["The COVID-19 pandemic is challenging the capacities of health systems in many countries. National healthcare services have to manage unexpected shortages of healthcare resources that have to be re-allocated according to the principles of fair and ethical prioritisation, in order to maintain the highest levels of care to all patients, ensure the safety of patients and healthcare workers, and save as many lives as possible. Also, cancer care services have to pursue restructuring, following the same evidence-based dispositions. In this article, we propose a guidance to the management of pancreatic cancer during the pandemic, prioritised according to a three-tiered framework, and based on expert clinical judgement and magnitude of benefit expected from specific interventions. Since the availability of resources for diagnostic procedures, surgery and postoperative care, systemic therapy and radiotherapy may differ, the authors have separated the prioritisation analyses. The impact of postponing or abrogating cancer interventions on outcomes according to a high, medium or low priority scale is outlined and discussed. The implementation of healthcare services using telemedicine is explored; it reveals itself as functional and effective for limiting patients' need to travel to centres and thereby has the potential to reduce diffusion of SARS-CoV-2. Pancreatic cancer demands a considerable amount of medical resources. Therefore, the redefinition of its diagnostic and therapeutic algorithms with a rigorous method is crucial in order to ensure the highest quality of continuum of care in the broader context of the pandemic and the challenged healthcare systems."],"journal":"ESMO Open","authors":["Catanese, Silvia","Pentheroudakis, George","Douillard, Jean-Yves","Lordick, Florian"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423899","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/esmoopen-2020-000804","keywords":["covid-19 pandemic"],"topics":["Prevention"],"weight":1,"_version_":1667252837840584704,"score":1043.5168},{"pmid":32439716,"title":"ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.","text":["ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.","The global preparedness and response to the rapid escalation to severe acute respiratory syndrome coronavirus (SARS-CoV)-2-related disease (COVID-19) to a pandemic proportion has demanded the formulation of a reliable, useful and evidence-based mechanism for health services prioritisation, to achieve the highest quality standards of care to all patients. The prioritisation of high value cancer interventions must be embedded in the agenda for the pandemic response, ensuring that no inconsistency or discrepancy emerge in the health planning processes.The aim of this work is to organise health interventions for breast cancer management and research in a tiered framework (high, medium, low value), formulating a scheme of prioritisation per clinical cogency and intrinsic value or magnitude of benefit. The public health tools and schemes for priority setting in oncology have been used as models, aspiring to capture clinical urgency, value in healthcare, community goals and fairness, while respecting the principles of benevolence, non-maleficence, autonomy and justice.We discuss the priority health interventions across the cancer continuum, giving a perspective on the role and meaning to maintain some services (undeferrable) while temporarily abrogate some others (deferrable). Considerations for implementation and the essential link to pre-existing health services, especially primary healthcare, are addressed, outlining a framework for the development of effective and functional services, such as telemedicine.The discussion covers the theme of health systems strategising, and why oncology care, in particular breast cancer care, should be maintained in parallel to pandemic control measures, providing a pragmatic clinical model within the broader context of public healthcare schemes.","ESMO Open","de Azambuja, Evandro","Trapani, Dario","Loibl, Sibylle","Delaloge, Suzette","Senkus, Elzbieta","Criscitiello, Carmen","Poortman, Philip","Gnant, Michael","Di Cosimo, Serena","Cortes, Javier","Cardoso, Fatima","Paluch-Shimon, Shani","Curigliano, Giuseppe","32439716"],"abstract":["The global preparedness and response to the rapid escalation to severe acute respiratory syndrome coronavirus (SARS-CoV)-2-related disease (COVID-19) to a pandemic proportion has demanded the formulation of a reliable, useful and evidence-based mechanism for health services prioritisation, to achieve the highest quality standards of care to all patients. The prioritisation of high value cancer interventions must be embedded in the agenda for the pandemic response, ensuring that no inconsistency or discrepancy emerge in the health planning processes.The aim of this work is to organise health interventions for breast cancer management and research in a tiered framework (high, medium, low value), formulating a scheme of prioritisation per clinical cogency and intrinsic value or magnitude of benefit. The public health tools and schemes for priority setting in oncology have been used as models, aspiring to capture clinical urgency, value in healthcare, community goals and fairness, while respecting the principles of benevolence, non-maleficence, autonomy and justice.We discuss the priority health interventions across the cancer continuum, giving a perspective on the role and meaning to maintain some services (undeferrable) while temporarily abrogate some others (deferrable). Considerations for implementation and the essential link to pre-existing health services, especially primary healthcare, are addressed, outlining a framework for the development of effective and functional services, such as telemedicine.The discussion covers the theme of health systems strategising, and why oncology care, in particular breast cancer care, should be maintained in parallel to pandemic control measures, providing a pragmatic clinical model within the broader context of public healthcare schemes."],"journal":"ESMO Open","authors":["de Azambuja, Evandro","Trapani, Dario","Loibl, Sibylle","Delaloge, Suzette","Senkus, Elzbieta","Criscitiello, Carmen","Poortman, Philip","Gnant, Michael","Di Cosimo, Serena","Cortes, Javier","Cardoso, Fatima","Paluch-Shimon, Shani","Curigliano, Giuseppe"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439716","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/esmoopen-2020-000793","keywords":["covid-19","esmo adapted recommendations","breast cancer"],"topics":["Prevention"],"weight":1,"_version_":1667523504795287552,"score":566.06714},{"pmid":32342872,"pmcid":"PMC7184972","title":"A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises.","text":["A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises.","OBJECTIVE: To derive evidence-based recommendations for the optimal utilisation of resources during unexpected shortage of radiotherapy capacity. METHODS AND MATERIALS: We have undertaken a rapid review of published literature on the role of radiotherapy in the multimodality treatment of paediatric cancers governing the European practice of paediatric radiotherapy. The derived data has been discussed with expert paediatric radiation oncologists to derive a hierarchy of recommendations. RESULTS: The general recommendations to mitigate the potential detriment of an unexpected shortage of radiotherapy facilities include: (1) maintain current standards of care as long as possible (2) refer to another specialist paediatric radiotherapy department with similar level of expertise (3) prioritise use of existing radiotherapy resources to treat patients with tumours where radiotherapy has the most effect on clinical outcome (4) use chemotherapy to defer the start of radiotherapy where timing of radiotherapy is not expected to be detrimental (5) active surveillance for low-grade tumours if appropriate and (6) consider iso-effective hypofractionated radiotherapy regimens only for selected patients with predicted poor prognosis. The effectiveness of radiotherapy and recommendations for prioritisation of its use for common and challenging paediatric tumours are discussed. CONCLUSION: This review provides evidence-based treatment recommendations during unexpected shortage of paediatric radiotherapy facilities. It has wider applications for the optimal utilization of facilities, to improve clinical outcome in low- and middle-income countries, where limited resources continue to be a challenge.","Radiother Oncol","Janssens, Geert O","Mandeville, Henry C","Timmermann, Beate","Maduro, John H","Alapetite, Claire","Padovani, Laetitia","Horan, Gail","Lassen-Ramshad, Yasmin","Dieckmann, Karin","Ruebe, Christian","Thorp, Nicky","Gandola, Lorenza","Ajithkumar, Thankamma","Boterberg, Tom","32342872"],"abstract":["OBJECTIVE: To derive evidence-based recommendations for the optimal utilisation of resources during unexpected shortage of radiotherapy capacity. METHODS AND MATERIALS: We have undertaken a rapid review of published literature on the role of radiotherapy in the multimodality treatment of paediatric cancers governing the European practice of paediatric radiotherapy. The derived data has been discussed with expert paediatric radiation oncologists to derive a hierarchy of recommendations. RESULTS: The general recommendations to mitigate the potential detriment of an unexpected shortage of radiotherapy facilities include: (1) maintain current standards of care as long as possible (2) refer to another specialist paediatric radiotherapy department with similar level of expertise (3) prioritise use of existing radiotherapy resources to treat patients with tumours where radiotherapy has the most effect on clinical outcome (4) use chemotherapy to defer the start of radiotherapy where timing of radiotherapy is not expected to be detrimental (5) active surveillance for low-grade tumours if appropriate and (6) consider iso-effective hypofractionated radiotherapy regimens only for selected patients with predicted poor prognosis. The effectiveness of radiotherapy and recommendations for prioritisation of its use for common and challenging paediatric tumours are discussed. CONCLUSION: This review provides evidence-based treatment recommendations during unexpected shortage of paediatric radiotherapy facilities. It has wider applications for the optimal utilization of facilities, to improve clinical outcome in low- and middle-income countries, where limited resources continue to be a challenge."],"journal":"Radiother Oncol","authors":["Janssens, Geert O","Mandeville, Henry C","Timmermann, Beate","Maduro, John H","Alapetite, Claire","Padovani, Laetitia","Horan, Gail","Lassen-Ramshad, Yasmin","Dieckmann, Karin","Ruebe, Christian","Thorp, Nicky","Gandola, Lorenza","Ajithkumar, Thankamma","Boterberg, Tom"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342872","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.radonc.2020.04.035","keywords":["covid-19","coronavirus","paediatric","radiotherapy","resources","treatment"],"locations":["optimal"],"topics":["Prevention"],"weight":1,"_version_":1666138495145476096,"score":324.91882},{"pmid":32426441,"pmcid":"PMC7230138","title":"Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.","text":["Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.","BACKGROUND: Relying on capacity increases and patient transfers to deal with the huge and continuous inflow of COVID-19 critically ill patients is a strategy limited by finite human and logistical resources. RATIONALE: Prioritising both critical care initiation and continuation is paramount to save the greatest number of lives. It enables to allocate scarce resources in priority to those with the highest probability of benefiting from them. It is fully ethical provided it relies on objective and widely shared criteria, thus preventing arbitrary decisions and guaranteeing equity. Prioritisation seeks to fairly allocate treatments, maximise saved lives, gain indirect life benefits from prioritising exposed healthcare and similar workers, give priority to those most penalised as a last resort, and apply similar prioritisation schemes to all patients. PRIORITISATION STRATEGY: Prioritisation schemes and their criteria are adjusted to the level of resource scarcity: strain (level A) or saturation (level B). Prioritisation yields a four level priority for initiation or continuation of critical care: P1 - high priority, P2 - intermediate priority, P3 - not needed, P4 - not appropriate. Prioritisation schemes take into account the patient's wishes, clinical frailty, pre-existing chronic condition, along with severity and evolution of acute condition. Initial priority level must be reassessed, at least after 48 h once missing decision elements are available, at the typical turning point in the disease's natural history (ICU days 7 to 10 for COVID-19), and each time resource scarcity levels change. For treatments to be withheld or withdrawn, a collegial decision-making process and information of patient and/or next of kin are paramount. PERSPECTIVE: Prioritisation strategy is bound to evolve with new knowledge and with changes within the epidemiological situation.","Anaesth Crit Care Pain Med","Leclerc, Thomas","Donat, Nicolas","Donat, Alexis","Pasquier, Pierre","Nicolas, Libert","Schaeffer, Elodie","D'aranda, Erwan","Cotte, Jean","Fontaine, Bruno","Perrigault, Pierre-Francois","Michel, Fabrice","Muller, Laurent","Meaudre, Eric","Veber, Benoit","32426441"],"abstract":["BACKGROUND: Relying on capacity increases and patient transfers to deal with the huge and continuous inflow of COVID-19 critically ill patients is a strategy limited by finite human and logistical resources. RATIONALE: Prioritising both critical care initiation and continuation is paramount to save the greatest number of lives. It enables to allocate scarce resources in priority to those with the highest probability of benefiting from them. It is fully ethical provided it relies on objective and widely shared criteria, thus preventing arbitrary decisions and guaranteeing equity. Prioritisation seeks to fairly allocate treatments, maximise saved lives, gain indirect life benefits from prioritising exposed healthcare and similar workers, give priority to those most penalised as a last resort, and apply similar prioritisation schemes to all patients. PRIORITISATION STRATEGY: Prioritisation schemes and their criteria are adjusted to the level of resource scarcity: strain (level A) or saturation (level B). Prioritisation yields a four level priority for initiation or continuation of critical care: P1 - high priority, P2 - intermediate priority, P3 - not needed, P4 - not appropriate. Prioritisation schemes take into account the patient's wishes, clinical frailty, pre-existing chronic condition, along with severity and evolution of acute condition. Initial priority level must be reassessed, at least after 48 h once missing decision elements are available, at the typical turning point in the disease's natural history (ICU days 7 to 10 for COVID-19), and each time resource scarcity levels change. For treatments to be withheld or withdrawn, a collegial decision-making process and information of patient and/or next of kin are paramount. PERSPECTIVE: Prioritisation strategy is bound to evolve with new knowledge and with changes within the epidemiological situation."],"journal":"Anaesth Crit Care Pain Med","authors":["Leclerc, Thomas","Donat, Nicolas","Donat, Alexis","Pasquier, Pierre","Nicolas, Libert","Schaeffer, Elodie","D'aranda, Erwan","Cotte, Jean","Fontaine, Bruno","Perrigault, Pierre-Francois","Michel, Fabrice","Muller, Laurent","Meaudre, Eric","Veber, Benoit"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426441","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.accpm.2020.05.008","keywords":["covid-19","critical care","ethics","pandemic","prioritisation","triage"],"topics":["Prevention"],"weight":1,"_version_":1667252837952782337,"score":281.0974},{"pmid":32452949,"title":"Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.","text":["Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.","OBJECTIVE: The COVID-19 pandemic requires to conscientiously weigh \"timely surgical intervention\" for colorectal cancer against efforts to conserve hospital resources and protect patients and health care providers. SUMMARY BACKGROUND DATA: Professional societies provided ad-hoc guidance at the outset of the COVID-19 pandemic on deferral of surgical and perioperative interventions, but these lack specific parameters to determine the optimal timing of surgery. METHODS: Using the GRADE system, published evidence was analyzed to generate weighted statements for stage, site, acuity of presentation and hospital setting to specify when surgery should be pursued, the time and duration of oncologically acceptable delays, and when to utilize non-surgical modalities to bridge the waiting period. RESULTS: Colorectal cancer surgeries - prioritized as emergency, urgent with (a) imminent emergency or (b) oncologically urgent, or elective - were matched against the phases of the pandemic. Surgery in COVID-19 positive patients must be avoided. Emergent and imminent emergent cases should mostly proceed unless resources are exhausted. Standard practices allow for postponement of elective cases and deferral to nonsurgical modalities of stage II/III rectal and metastatic colorectal cancer. Oncologically urgent cases may be delayed for 6(-12) weeks without jeopardizing oncological outcomes. Outside established principles, administration of nonsurgical modalities is not justified and increases the vulnerability of patients. CONCLUSION: The COVID-19 pandemic has stressed already limited health care resources and forced rationing, triage and prioritization of care in general, specifically of surgical interventions. Established guidelines allow for modifications of optimal timing and type of surgery for colorectal cancer during an unrelated pandemic.","Ann Surg","O'Leary, Michael P","Choong, Kevin C","Thornblade, Lucas W","Fakih, Marwan G","Fong, Yuman","Kaiser, Andreas M","32452949"],"abstract":["OBJECTIVE: The COVID-19 pandemic requires to conscientiously weigh \"timely surgical intervention\" for colorectal cancer against efforts to conserve hospital resources and protect patients and health care providers. SUMMARY BACKGROUND DATA: Professional societies provided ad-hoc guidance at the outset of the COVID-19 pandemic on deferral of surgical and perioperative interventions, but these lack specific parameters to determine the optimal timing of surgery. METHODS: Using the GRADE system, published evidence was analyzed to generate weighted statements for stage, site, acuity of presentation and hospital setting to specify when surgery should be pursued, the time and duration of oncologically acceptable delays, and when to utilize non-surgical modalities to bridge the waiting period. RESULTS: Colorectal cancer surgeries - prioritized as emergency, urgent with (a) imminent emergency or (b) oncologically urgent, or elective - were matched against the phases of the pandemic. Surgery in COVID-19 positive patients must be avoided. Emergent and imminent emergent cases should mostly proceed unless resources are exhausted. Standard practices allow for postponement of elective cases and deferral to nonsurgical modalities of stage II/III rectal and metastatic colorectal cancer. Oncologically urgent cases may be delayed for 6(-12) weeks without jeopardizing oncological outcomes. Outside established principles, administration of nonsurgical modalities is not justified and increases the vulnerability of patients. CONCLUSION: The COVID-19 pandemic has stressed already limited health care resources and forced rationing, triage and prioritization of care in general, specifically of surgical interventions. Established guidelines allow for modifications of optimal timing and type of surgery for colorectal cancer during an unrelated pandemic."],"journal":"Ann Surg","authors":["O'Leary, Michael P","Choong, Kevin C","Thornblade, Lucas W","Fakih, Marwan G","Fong, Yuman","Kaiser, Andreas M"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452949","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/SLA.0000000000004029","topics":["Prevention"],"weight":1,"_version_":1667881798467584002,"score":260.9204}]}